Latest News- Nasal Cannula Market: High flow nasal cannula is expected to lead the Product segment during 2024-2028
The Nasal Cannula Market is being driven by Growing prevalence of smoking
The Nasal Cannula Market is expected to grow at a CAGR of 4.49% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 189.5 million. In the healthcare industry, Heated Humidified High-Flow Nasal Cannulas (HHFNCs) have emerged as a preferred solution for delivering a high volume of medical gasses to individuals with respiratory disorders. These advanced nasal cannulas offer a clean wash-out path for the upper airway by providing ideal body saturation vapor pressure that matches human body temperature. HHFNCs are increasingly used in the treatment of conditions such as hypoxemia, shortness of breath, acute asthma, and pulmonary embolism. Furthermore, they are beneficial in post-operative procedures to optimally supply supplemental oxygen to patients. Capable of delivering up to 60 LPM, these nasal cannulas help reduce the need for intubation and non-invasive ventilation in certain cases.
Get more information on Nasal Cannula Market by requesting a sample report
Which Factors Are Causing a Surge in Market Growth?
The market is segmented based on Product (High flow nasal cannula, Low flow nasal cannula) Geography (North America, Europe, Asia, Rest of World (ROW)).
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Key Features in Nasal Cannula Market Research Report
Find out which segment is leading the market by accessing the free PDF report
The Nasal Cannulas Market has witnessed significant growth due to the increasing prevalence of respiratory failures caused by various illnesses such as sleep apnea, pulmonary fibrosis, pneumonia, lung cancer, heart failure, and cystic fibrosis. Oxygen therapy, which includes the use of nasal cannulas, is a common treatment for these conditions. However, the use of oxygen therapy comes with risks, including pulmonary oxygen toxicity and lung damage, particularly when oxygen levels are not properly monitored. Nasal cannulas are a popular choice for oxygen delivery in both long-term care settings and ambulatory care. They offer several benefits, including ease of use, comfort, and portability. However, they can cause nasal dryness, which can lead to discomfort and even infection in some cases. Electrical oxygen systems and other oxygen supply equipment are used to ensure a consistent oxygen supply. Oxygen levels must be carefully monitored to prevent oxygen therapy risks, such as lung damage and respiratory failure. Newborns, particularly those with respiratory distress syndrome, also benefit from oxygen therapy using nasal cannulas. In summary, the nasal cannulas market is driven by the growing number of respiratory illnesses and the need for effective oxygen delivery systems. While oxygen therapy offers numerous benefits, it is essential to be aware of the risks and take appropriate precautions to ensure safe and effective use.
The global healthcare supplies market encompasses the sector dedicated to research and development of a diverse range of medical consumables, including nasal cannulas, used for the diagnosis and treatment of various health conditions. According to Technavio, the market size is determined by the consolidated revenue generated by manufacturers of medical supplies such as syringes, drapes, gloves, gowns, and nasal cannulas. The market's expansion will be fueled by several key drivers, most notably the increasing global population aging, with Europe projected to reach nearly one-quarter aging population by 2030, and the US following suit by 2050.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted